| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10912083 | Lung Cancer | 2005 | 4 Pages |
Abstract
Australasia has a strong record in clinical trials in malignant pleural mesothelioma (MPM), driven by the relatively high incidence of this disease in the region. Two current and three proposed trials in mesothelioma in this region are discussed, covering the diverse clinical scenarios of diagnosis and staging, health-related quality of life, maintenance therapy, prediction of response and combined modality treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anna K. Nowak,